What is Lenalidomide-dexamethasone (Rd)?

Category: Prescription Drugs

false

See also: Lenalidomide

Lenalidomide-dexamethasone, also known as Rd, is a regimen that may be used for the treatment of multiple myeloma. It includes lenalidomide, an anticancer agent, and dexamethasone, a corticosteroid.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 3
Moderate 17
Mild 7
None 3

Commonly reported side effects and conditions associated with Lenalidomide-dexamethasone (Rd)

Side effect Patients
Fatigue 4
Nausea 3
Chronic constipation 2
Chronic fatigue 2
Diarrhea 2
Muscle cramps 2

Show all 38 reported side effects

Dosages

Based on patients currently taking Lenalidomide-dexamethasone (Rd)

Dosage Patients
daily 1
weekly 1

Why patients stopped taking Lenalidomide-dexamethasone (Rd)

Multiple reasons could be selected

Reason Patients
Course of treatment ended 4
Doctor's advice 3
Side effects too severe 3
Other 2
Did not seem to work 1
See all 9 patients who've stopped taking Lenalidomide-dexamethasone (Rd)

Duration

Currently taking Lenalidomide-dexamethasone (Rd)

Duration Patients
1 - 2 years 1
2 - 5 years 2
5 - 10 years 2

Stopped taking Lenalidomide-dexamethasone (Rd)

Duration Patients
Less than 1 month 1
1 - 6 months 5
6 months - 1 year 1
2 - 5 years 2
Adherence
Adherence Evaluations
Always 25
Usually 1
Sometimes 1
Never taken as prescribed 3
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 2
A little hard to take 4
Not at all hard to take 24
Cost per month
Cost per month Evaluations
$200+ 3
$100-199 0
$50-99 1
$25-49 4
< $25 8
Not specified 14

What people switch to and from

Patients started taking Lenalidomide-dexamethasone (Rd) after stopping:

Treatment Patients
Bortezomib-cyclophosphamide-dexamethasone (VCd or CyBorD) 4
Bortezomib (Velcade) 1
Thalidomide-dexamethasone (Td) 1

Patients stopped taking Lenalidomide-dexamethasone (Rd) and switched to:

Treatment Patients
Bortezomib (Velcade) 1
Bortezomib-dexamethasone (Vd) 1
Bortezomib-lenalidomide-dexamethasone (VRd) 1
Lenalidomide (Revlimid) 1
Last updated:
There are no evaluations for Lenalidomide-dexamethasone (Rd).